肌萎缩侧索硬化多步假说再探讨:基因突变的作用
基于意大利肌萎缩侧索硬化(ALS)人群登记数据(2007-2015年,82%病例完成C9orf72、SOD1、TARDBP、FUS基因检测)及爱尔兰ALS数据验证,采用最小二乘回归分析年龄别发病率对数与年龄对数的关系。全人群呈线性关系(r²=0.98),斜率4.65(4.37-4.95),符合6步过程;C9orf72突变患者斜率2.22(1.74-2.29),符合3步过程,爱尔兰数据证实;SOD1符合2步过程,TARDBP符合4步过程。
要点
- 全人群年龄别发病率对数与年龄对数呈线性关系,斜率4.65(4.37-4.95),符合6步过程。
- C9orf72突变患者斜率2.22(1.74-2.29),符合3步过程,爱尔兰ALS登记数据证实。
- SOD1突变符合2步过程,TARDBP突变符合4步过程。
核心结论
- 携带基因突变的ALS患者较无突变者步骤数减少,支持ALS为多步过程,为解析ALS致病过程提供重要进展。
研究设计与样本
- 研究基于意大利ALS人群登记(2007-2015年),82%的 incident 病例完成C9orf72、SOD1、TARDBP和FUS基因分析。
- 以爱尔兰ALS病例数据(2006-2014年)作为验证。
- 对携带各基因致病性变异的亚组,采用最小二乘回归分析年龄别发病率对数与年龄对数的关系。
主要发现
- 1,077例完成基因检测的病例中,74例(6.9%)携带C9orf72突变,20例(1.9%)携带SOD1突变,15例(1.4%)携带TARDBP突变,3例(0.3%)携带FUS突变。
- 全人群年龄别发病率对数与年龄对数呈线性关系(r²=0.98),斜率估计值为4.65(4.37-4.95),符合6步过程。
- C9orf72突变患者分析显示线性关系(r²=0.94),斜率估计值为2.22(1.74-2.29),提示3步过程。
- 爱尔兰ALS登记数据证实了C9orf72突变患者的斜率估计值。
- SOD1的斜率估计值符合2步过程,TARDBP符合4步过程。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Amyotrophic lateral sclerosis (ALS) incidence rates are consistent with the hypothesis that ALS is a multistep process. We tested the hypothesis that carrying a large effect mutation might account for ≥1 steps through the effect of the mutation, thus leaving fewer remaining steps before ALS begins. METHODS: We generated incidence data from an ALS population register in Italy (2007-2015) for which genetic analysis for C9orf72, SOD1, TARDBP, and FUS genes was performed in 82% of incident cases. As confirmation, we used data from ALS cases diagnosed in the Republic of Ireland (2006-2014). We regressed the log of age-specific incidence against the log of age with least-squares regression for the subpopulation carrying disease-associated variation in each separate gene. RESULTS: Of the 1,077 genetically tested cases, 74 (6.9%) carried C9orf72 mutations, 20 (1.9%) had SOD1 mutations, 15 (1.4%) had TARDBP mutations, and 3 (0.3%) carried FUS mutations. In the whole population, there was a linear relationship between log incidence and log age (r2 = 0.98) with a slope estimate of 4.65 (4.37-4.95), consistent with a 6-step process. The analysis for C9orf72-mutated patients confirmed a linear relationship (r2 = 0.94) with a slope estimate of 2.22 (1.74-2.29), suggesting a 3-step process. This estimate was confirmed by data from the Irish ALS register. The slope estimate was consistent with a 2-step process for SOD1 and with a 4-step process for TARDBP. CONCLUSION: The identification of a reduced number of steps in patients with ALS with genetic mutations compared to those without mutations supports the idea of ALS as a multistep process and is an important advance for dissecting the pathogenic process in ALS.
引用
- Chiò A, Mazzini L, D'Alfonso S, et al. The multistep hypothesis of ALS revisited: The role of genetic mutations. Neurology. 2018. PMID: 30045958. doi:10.1212/WNL.0000000000005996
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。